About Medicines Law & Policy

Medicines Law & Policy brings together legal and policy experts in the field of access to medicines, international law, and public health. We provide policy and legal analysis, best practice models and other information that can be used by governments, non-governmental organisations, product development initiatives, funding agencies, UN agencies and others working to ensure the availability of effective, safe and affordable medicines for all.

Most of our research and advocacy work is funded by small family foundations. We occasionally do contract work for or joint projects with non-governmental organisations, governments, UN agencies and other international organisations, and academic institutions. While we endeavour to provide information that is as accurate as possible there will always be room for improvement. We welcome any comments you may have. The information provided on this website is not meant to be formal legal advice. ML&P is registered in the Netherlands.

ML&P's team of experts

Ellen ‘t Hoen, LLM PhD, is a lawyer and public health advocate with over 30 years of experience working on pharmaceutical and intellectual property policies. From 1999 until 2009 she was the director of policy for Médecins sans Frontières’ Campaign for Access to Essential Medicines. In 2009 she joined UNITAID in Geneva to set up the Medicines Patent Pool (MPP). She was the MPP’s first executive director until 2012. Between 2005 and 2021 she was listed five times as one of the 50 most influential people in intellectual property by the journal Managing Intellectual Property. She has worked as an advisor to a number of governments, NGOs and international organisations. She is currently a researcher at the University Medical Centre at the University of Groningen, The Netherlands. In 2020, she was appointed Officer of the Order of Oranje-Nassau, a royal award given by the King of the Netherlands for her international work on equitable access to affordable medicines. She has published widely on medicines law and policy issues. Her book “Private Patents and Public Health: Changing intellectual property rules for public health” published July 2016 was awarded the 2017 Prix Prescrire  for a “major reference work on access to medicines” by French healthcare journal La Revue Prescrire. She has a Masters of Laws from the University of Amsterdam and a PhD from the University of Groningen.

Kaitlin Mara, MSc, has been writing about international intellectual property and innovation policy for a decade. From 2007 to 2010 she was the Associate Editor at Intellectual Property Watch, where she reported on several World Health Organization negotiations, including the process that resulted in its Global Policy and Plan of Action on Innovation, Intellectual Property and Public Health. In 2010, she joined the newly-formed Medicines Patent Pool as its first head of communications.

Since 2014, she has consulted on issues of intellectual property and access to medicines, including for UNITAID, Médecins Sans Frontières and Health Action International. She is also the editor of Ellen ‘t Hoen’s latest book. When not working on access to medicines, she thinks about access to information and environmental technology. Kaitlin has a Masters of Science from the London School of Economics.

Katrina Perehudoff, MSc LLM PhD, is a health scientist and legal scholar with over a decade of experience in pharmaceutical policy. Katrina has five years of experience advocating for access to medicines and their rational use in European pharmaceutical policy at the NGOs Health Action International (the Netherlands) and The European Consumer Organisation (Belgium). From 2013 to 2015 Katrina managed the Belgian-arm of a multi-country clinical trial testing a new tool to improve hospital prescribing for older people at the Ghent University Hospital. Since 2015 she has consulted on human rights, intellectual property and pharmaceutical policy issues for non-profit organisations including the FXB Center for Health and Human Rights at Harvard University and the Medical Human Rights Network. Katrina is an alumna of the Comparative Program on Health & Society at the Munk School of Global Affairs (2017) and the Rotary Ambassadorial Scholarship program (2007-2008). Katrina is currently a post doctoral researcher at the International Centre for Reproductive Health- a WHO Collaborating Centre for Research on Sexual and Reproductive Health at the Ghent University. She holds a 2018-2019 Post Doctoral Research Fellowship at the Dalla Lana School of Public Health, University of Toronto. She has published on medicines policy and practice. She has a Masters of Science (health sciences) from the Vrije Universiteit Amsterdam, a Masters of Law (European law) from Ghent University, and a PhD from the University of Groningen.

Pascale Boulet, LLM, is a lawyer with over 20 years’ experience in intellectual property and access to medicines policies, with a particular focus on low and middle-income countries.

Pascale co-authored the first WHO publication on the impact of intellectual property on access to medicines, Globalization and Access to Drugs: Perspectives on the WTO/TRIPS Agreement, published in 1997. Since then, she has worked and consulted widely with international organizations and NGOs.

From 2010 to 2018, she served as patent database consultant to the Medicines Patent Pool (MPP) leading to the development of its landmark MedsPaL database.

Since 2017, Pascale has been acting as Intellectual Property and Access Leader with the Drugs for Neglected Diseases initiative (DNDi).

Pascale was previously Senior Legal Advisor of Médecins sans Frontières’ (MSF) Campaign for Access to Essential Medicines, and also served three years in the WHO Department on Essential Medicines. She holds a Master of Laws in International Economic Law from the University of Panthéon-Sorbonne in Paris.

Christopher Garrison, MA LLM MA PhD, is a legal advisor with over 20 years of experience on intellectual property issues. He qualified in private practice as a European Patent Attorney in 1996 before working in Industry on a range of patent prosecution, licensing and litigation matters. Having developed a more critical interest in the history, operation and outcome of the international intellectual property system, he became a consultant legal advisor to Médecins sans Frontières’ Campaign for Access to Essential Medicines in 2001. Subsequently he has also consulted on access to medicines, medical R&D and public / private collaboration issues for, for example, the World Health Organisation, the Bill and Melinda Gates Foundation, the Pharmaceutical R&D Policy Project at the London School of Economics and the Medicines Patent Pool. His published works in this field include the 2006 UNCTAD / ICTSD study on Exceptions to Patent Rights in Developing Countries. In addition to intellectual property issues, Christopher’s broad ranging interests in science, law and policy have expanded his work into areas such as the history of cultural property incentive regimes, the reflection of the Common Heritage of Mankind principle in the United Nations Convention on the Law of the Sea and in other governance regimes including those relating to Outer Space, and scientific and policy problems posed by global biological and geophysical threats. He has a Masters Degree in Physics from the University of Oxford, a Masters Degree in (International and Comparative) Law from the School of Oriental and African Studies of the University of London, a Masters Degree in Archaeology from the Institute of Archaeology at University College London and, most recently, a PhD in Volcanology and Climatology from the UCL Hazard Centre, Earth Sciences, University College London. He attended the Hague Academy of International Law in 2005.

Monty Dunn, BA (Cantab), is a medical student and health activist studying at Cambridge University. Over the last 4 years, he has held a number of roles within Universities Allied for Essential Medicines, most recently as Co-National coordinator of UAEM UK. In this role, he initiated and steered UAEM UK’s national campaign for sector-wide adoption of simple access clauses in technology transfer agreements between UK TTOs and the private sector. This builds on the work of UAEM North America and the Medicines Patent Pool to construct and implement an ‘Affordable Access Provision’ in the license agreements of UCLA and UC Berkeley. Negotiations with UK TTOs (and TTO networks) is ongoing but has seen significant progress.

His work at Medicines Law & Policy centres around the TRIPS Flexibilities Database.

Outside of access to medicines, his interests include Anti-Microbial Stewardship and the health of vulnerable populations such as Refugees and Gypsy, Roma and Travellers. Monty holds a 1st class intercalated BA (Cantab) in Manufacturing Engineering and is due to graduate with a MB BChir from Cambridge in June 2025.